SCHEMBL6311566

SCHEMBL6311566

CCCc1cc(OC)c2cc(/C(N)=N/O)ccc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.47
MCHR1 Q99705 5/20 0.43
ASIC3 Q9UHC3 1/20 0.39
GAA P10253 4/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 3/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
F10 P00742 1/20 0.37
PDE10A Q9Y233 3/20 0.36
LMNA P02545 2/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6221754 1.00 RECQL (0.47) RECQLMCHR1ASIC3GAARAB9A
SCHEMBL6204138 0.82 MCHR1 (0.50) MCHR1ASIC3RAB9AMEN1KMT2A
SCHEMBL6203321 0.78 HSD17B2 (0.51) MCHR1RAB9AMEN1KMT2AKDM4E
SCHEMBL6221751 0.78 MCHR1 (0.47) MCHR1ASIC3MEN1KMT2AKDM4E
Chimanine A SCHEMBL8588818 0.73 HPGD (0.59) GAAKDM4EPDE10ALMNAMAPT
SCHEMBL6201487 0.72 CTSK (0.43) MCHR1MEN1KMT2AKDM4EESR1
SCHEMBL4259484 0.71 MCHR1 (0.62) MCHR1GAARAB9AMEN1KMT2A
SCHEMBL31587738 0.70 ESR1 (0.58) MCHR1GAAMEN1KMT2AKDM4E
SCHEMBL30506314 0.69 RECQL (0.77) RECQLGAARAB9AMEN1KMT2A
SCHEMBL1660322 0.69 RECQL (0.77) RECQLGAARAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009815-A1 4-Aminoquinoline compounds DEVITA ROBERT J (US) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009815-A1 4-Aminoquinoline compounds MCHR1, MCHR2, MC5R RECQL 530/4885MCHR1 1/4885ASIC3 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.